Related Experiment Videos
Otological lesions in pachyonychia congenita syndrome
R F Bento1, M H Guatimosim, R de L Bensadon
1Department of Otolaryngology, University of São Paulo, Brazil.
Abstract:
The authors report a case of a patient with pachyonychia congenita syndrome, a rare genodermatosis inherited as an autosomal dominant trait, who also had otological lesions beyond the other classic signs and symptoms of the syndrome. Many kinds of treatment have already been proposed, but all failed to show satisfactory results. A new, cheap and easy-to-use treatment was developed in this study, using keratoplastics interpolated with humectant lotion for 90 days. The results after three years of follow-up are still thoroughly satisfactory.
Insights
A novel treatment using keratoplastics and humectant lotion effectively managed pachyonychia congenita syndrome, including rare otological lesions. This affordable therapy showed sustained, satisfactory results over a three-year follow-up period.
Area of Science:
- Dermatology
- Genetics
- Otolaryngology
Background:
- Pachyonychia congenita syndrome is a rare autosomal dominant genodermatosis.
- Classic signs and symptoms include nail dystrophy and skin abnormalities.
- Otological lesions represent an uncommon manifestation of the syndrome.
Observation:
- A patient with pachyonychia congenita syndrome presented with significant otological lesions.
- Previous treatment modalities for the syndrome have yielded unsatisfactory outcomes.
- A new therapeutic approach was developed for this case.
Findings:
- The new treatment involved a 90-day regimen of keratoplastics interpolated with humectant lotion.
- This intervention proved to be cost-effective and simple to administer.
- The treatment demonstrated thoroughly satisfactory results during a three-year follow-up.
Implications:
- This study introduces a promising, accessible treatment option for pachyonychia congenita syndrome.
- The findings suggest potential efficacy in managing both dermatological and otological manifestations.
- Further research may validate this approach for broader clinical application in rare genodermatoses.